Search

everythinglearnresearchcommunity

for

Search:↓

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Researchers found four genes that could help diagnose severe alopecia areata early.

Adding L-glutamine to the diet of Hanwoo steers may boost their immune system and help them cope with heat.

Higher levels of miR-203 may contribute to hair loss in alopecia areata.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Testosterone's effects on COVID-19 are unclear and need more research.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Substances from Chinese medicines show promise for immune support and disease prevention, but the way they are processed affects their effectiveness.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.